Talking Point: Path Ahead For U.S. Generic Market And Indian Pharma Sector
  • 8 months ago
Talking Point | Why #InCred’s Aditya Khemka is less constructive on the U.S. generic players, while preferring other segments in the healthcare space?
Recommended